These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34063776)

  • 41. Calcineurin inhibitor toxicity in renal allografts: morphologic clues from protocol biopsies.
    Sharma A; Jain S; Gupta R; Guleria S; Agarwal S; Dinda A
    Indian J Pathol Microbiol; 2010; 53(4):651-7. PubMed ID: 21045386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular pathways involved in loss of graft function in kidney transplant recipients.
    Mas VR; Archer KJ; Scian M; Maluf DG
    Expert Rev Mol Diagn; 2010 Apr; 10(3):269-84. PubMed ID: 20370585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium.
    Jacobson PA; Schladt D; Israni A; Oetting WS; Lin YC; Leduc R; Guan W; Lamba V; Matas AJ;
    Transplantation; 2012 Mar; 93(6):624-31. PubMed ID: 22334041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulated Expression of Circulating MicroRNAs in Kidney Transplant Recipients With Interstitial Fibrosis and Tubular Atrophy.
    Zununi Vahed S; Poursadegh Zonouzi A; Ghanbarian H; Ghojazadeh M; Samadi N; Ardalan M
    Iran J Kidney Dis; 2017 Jul; 11(4):309-318. PubMed ID: 28794294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
    Rivelli RF; Gonçalves RT; Leite M; Santos MA; Delgado AG; Cardoso LR; Takiya CM
    Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic allograft dysfunction: major contributing factors.
    Ganji MR; Harririan A
    Iran J Kidney Dis; 2012 Mar; 6(2):88-93. PubMed ID: 22388603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.
    Zhang W; Yi Z; Keung KL; Shang H; Wei C; Cravedi P; Sun Z; Xi C; Woytovich C; Farouk S; Huang W; Banu K; Gallon L; Magee CN; Najafian N; Samaniego M; Djamali A; Alexander SI; Rosales IA; Smith RN; Xiang J; Lerut E; Kuypers D; Naesens M; O'Connell PJ; Colvin R; Menon MC; Murphy B
    J Am Soc Nephrol; 2019 Aug; 30(8):1481-1494. PubMed ID: 31278196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
    Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH
    Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.
    Quaglia M; Merlotti G; Guglielmetti G; Castellano G; Cantaluppi V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protocol biopsies in pediatric renal transplantation: a precious tool for clinical management.
    Zotta F; Guzzo I; Morolli F; Diomedi-Camassei F; Dello Strologo L
    Pediatr Nephrol; 2018 Nov; 33(11):2167-2175. PubMed ID: 29980849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrative Omics Analysis Unravels Microvascular Inflammation-Related Pathways in Kidney Allograft Biopsies.
    Tinel C; Lamarthée B; Callemeyn J; Van Loon E; Sauvaget V; Morin L; Aouni L; Rabant M; Gwinner W; Marquet P; Naesens M; Anglicheau D
    Front Immunol; 2021; 12():738795. PubMed ID: 34795664
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Everolimus for BKV nephropathy in kidney transplant recipients: a prospective, controlled study.
    Bussalino E; Marsano L; Parodi A; Russo R; Massarino F; Ravera M; Gaggero G; Fontana I; Garibotto G; Zaza G; Stallone G; Paoletti E
    J Nephrol; 2021 Apr; 34(2):531-538. PubMed ID: 32533451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of everolimus in chronic allograft nephropathy.
    Das U; Dakshinamurty KV
    Saudi J Kidney Dis Transpl; 2013 Sep; 24(5):910-6. PubMed ID: 24029254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2.
    Wojciechowski D; Vincenti F
    Adv Chronic Kidney Dis; 2016 Sep; 23(5):306-311. PubMed ID: 27742385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients.
    Pescovitz MD; Govani M
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 2):S16-21. PubMed ID: 11583940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conversion to Everolimus in Kidney Transplant Recipients With Calcineurin Inhibitor-Induced Nephropathy: 3 Case Reports.
    Nanmoku K; Shinzato T; Kubo T; Shimizu T; Yagisawa T
    Transplant Proc; 2019 Jun; 51(5):1424-1427. PubMed ID: 31060742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
    Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
    Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcineurin-inhibitor related nephrotoxicity- reversibility in paediatric liver transplant recipients.
    Aw MM; Samaroo B; Baker AJ; Verma A; Rela M; Heaton ND; Mieli-Vergani G; Dhawan A
    Transplantation; 2001 Aug; 72(4):746-9. PubMed ID: 11544444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.